Is DMPWW or PLD a better dividend investment in 2026?

DMPWW currently yields 2000000.00% with a 5% 5-year dividend growth rate. PLD yields 3.10% with 5% growth. The better choice depends on your goal: DMPWW offers higher current income.

What is the dividend yield difference between DMPWW and PLD?

DMPWW has a forward dividend yield of 2000000.00% ($2.00/share annually). PLD yields 3.10% ($4.10/share annually). The yield gap is 1999996.90 percentage points.

Home › Compare › DMPWW vs PLD

DMPWW vs PLD: Dividend Comparison 2026

DMPWW yields 2000000.00% · PLD yields 3.10%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 DMPWW wins by $1.6247481716182984e+23M in total portfolio value

INVESTMENT

TIME HORIZON10 years

DMPWW

● Live price

2000000.00%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

-50%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$1.6247481716182984e+23M

Annual income

$147,608,011,402,949,780,000,000,000,000.00

Full DMPWW calculator →

PLD

● Live price

3.10%

Share price

$132.18

Annual div

$4.10

5Y div CAGR

74.4%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$5.91M

Annual income

$4,750,725.19

Full PLD calculator →

Portfolio growth — DMPWW vs PLD

📍 DMPWW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	DMPWW	PLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, DMPWW + PLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

DMPWW pays

PLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DMPWW

Annual income on $10K today (after 15% tax)

$170,000,000.00/yr

After 10yr DRIP, annual income (after tax)

$125,466,809,692,507,310,000,000,000,000.00/yr

PLD

Annual income on $10K today (after 15% tax)

$263.66/yr

After 10yr DRIP, annual income (after tax)

$4,038,116.41/yr

At 15% tax rate, DMPWW beats the other by $125,466,809,692,507,310,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DMPWW + PLD for your $10,000?

DMPWW: 50%PLD: 50%

100% PLD50/50100% DMPWW

Portfolio after 10yr

$8.123740858091492e+22M

Annual income

$73,804,005,701,474,890,000,000,000,000.00/yr

Blended yield

90.85%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

DMPWW

No analyst data

Altman Z

-32.8

Piotroski

3/9

PLD

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$136.00

+2.9% upside vs current

Range: $119.00 — $155.00

Altman Z

1.9

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DMPWW buys

PLD buys

No recent congressional trades found for DMPWW or PLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricDMPWWPLD

Forward yield	2000000.00% ✓	3.10%
Annual dividend / share	$2.00	$4.10 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	-50%	74.4% ✓
Portfolio after 10y	$1.6247481716182984e+23M	$5.91M ✓
Annual income after 10y	$147,608,011,402,949,780,000,000,000,000.00 ✓	$4,750,725.19
Total dividends collected	$1.6146053563276882e+23M	$5.78M ✓
Payment frequency	quarterly	quarterly
Sector	Stock	REIT

Year-by-year: DMPWW vs PLD ($10,000, DRIP)

Year	DMPWW Portfolio	DMPWW Income/yr	PLD Portfolio	PLD Income/yr	Gap
1← crossover	$100,010,700	$100,000,000.00	$11,241	$540.96	+$100.00M → DMPWW
2	$467,446,731,075	$467,339,719,626.17	$13,019	$991.13	+$467446.72M → DMPWW
3	$1,021,215,363,816,662	$1,020,715,195,814,411.90	$15,801	$1,870.97	+$1021215363.80M → DMPWW
4	$1,043,112,617,104,109,200	$1,042,019,916,664,825,300.00	$20,609	$3,701.21	+$1043112617104.09M → DMPWW
5	$498,482,143,759,731,400,000	$497,366,013,259,430,040,000.00	$29,919	$7,867.97	+$498482143759731.38M → DMPWW
6	$111,599,275,650,097,780,000,000	$111,065,899,756,274,860,000,000.00	$50,631	$18,617.74	+$111599275650097776.00M → DMPWW
7	$11,738,678,336,351,557,000,000,000	$11,619,267,111,405,953,000,000,000.00	$105,528	$51,352.20	+$11738678336351557632.00M → DMPWW
8	$583,674,362,697,175,100,000,000,000	$571,113,976,877,278,900,000,000,000.00	$287,364	$174,449.42	+$583674362697175072768.00M → DMPWW
9	$13,894,210,989,607,547,000,000,000,000	$13,269,679,421,521,570,000,000,000,000.00	$1,081,760	$774,280.77	+$1.3894210989607547e+22M → DMPWW
10	$162,474,817,161,829,840,000,000,000,000	$147,608,011,402,949,780,000,000,000,000.00	$5,908,209	$4,750,725.19	+$1.6247481716182984e+23M → DMPWW

DMPWW vs PLD: Complete Analysis 2026

DMPWW — Stock

Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme, as well as other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intrinsic pontine glioma; and REM-001, a late stage photodynamic therapy for the treatment of cutaneous metastatic breast cancer, basal cell carcinoma nevus syndrome, and access graft failure in hemodialysis patients. Kintara Therapeutics, Inc. has a strategic collaboration with Guangxi Wuzhou Pharmaceutical (Group) Co. Ltd. to manufacture and sell VAL-083 in China. The company was formerly known as DelMar Pharmaceuticals, Inc. and changed its name to Kintara Therapeutics, Inc. in August 2020. Kintara Therapeutics, Inc. was incorporated in 2009 and is headquartered in San Diego, California.

Full DMPWW Calculator →

PLD — REIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →

📬

Get this DMPWW vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DMPWW vs SCHD DMPWW vs JEPI DMPWW vs O DMPWW vs KO DMPWW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.